AIxCrypto Holdings, Inc. (AIXC): Nasdaq/NYSE listing notice — Qualigen Therapeutics regains Nasdaq compliance after filing overdue 10-K

AIxCrypto Holdings, Inc.

Received delisting notice on April 20, 2023 for late filing of 2022 Form 10-K.
Filed the delinquent Form 10-K on May 2, 2023.
On May 4, 2023, Nasdaq confirmed compliance with Listing Rule 5250(c)(1); matter closed.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

AIxCrypto Holdings, Inc. received a nasdaq compliance regained notice regarding late filing (rules 5250(c)(1)).

Exchange: nasdaq
Notice: compliance regained
Deficiency: late filing
Rules: 5250(c)(1)

Exact text from the filing

May 4, 2023 that it had regained compliance with Nasdaq’s listing rule 5250(c)(1) as a result thereof and that the matter is now closed. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. QUALIGEN THERAPEUTICS, INC. Date: May 5, 2023 By: /s/ Michael S. Poirier Michael S. Poirier, Chief Executive Officer

View on SEC.gov

50 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

AIxCrypto Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-23-015599

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.